12EUROPEANUROLOGYXXX(XXXX)XXX
prostatectomyurinaryincontinenceandthecorrelationbetweencontinenceballoonimplants:functionalresultsfromasingle
preoperativeurodynamicandsurgicaloutcomes.Urologycenterprospectivestudy.JUrol2011;186:198–203.
2008;71:85–9.[137]MagistroGetal.Newintraprostaticinjectablesandprostatic
[124]LaiHHetal.UrodynamictestinginevaluationofpostradicalurethralliftformaleLUTS.NatRevUrol2015;12:461–71.
prostatectomyincontinencebeforearti?cialurinarysphincter[138]DuthieJBetal.Botulinumtoxininjectionsforadultswith
implantation.Urology2009;73:1264–9.overactivebladdersyndrome.CochraneDatabaseSystRev
[125]QueissertFetal.High/low-volumecenterexperiencepredicts2011;12:CD005493.
outcomeofAMS800inmalestressincontinence:resultsofalarge[139]MangeraAetal.Contemporarymanagementoflowerurinary
middleEuropeanmulticentercaseseries.NeurourolUrodyntractdiseasewithbotulinumtoxinA:asystematicreviewofBotox
2020;39:1856–61.(onabotulinumtoxinA)andDysport(abobotulinumtoxinA).Eur
[126]DosanjhAetal.Anationalstudyofarti?cialurinarysphincterandUrol2011;60:784–95.
maleslingimplantationafterradicalprostatectomyinEngland.[140]NittiVWetal.OnabotulinumtoxinAforthetreatmentofpatients
BJUInt2020;125:467–75.withoveractivebladderandurinaryincontinence:resultsofa
[127]VanderAaFetal.Thearti?cialurinarysphincterafteraquarterofphase3,randomized,placebocontrolledtrial.JUrol
acentury:acriticalsystematicreviewofitsuseinmalenon-2013;189:2186–93.
neurogenicincontinence.EurUrol2013;63:681–9.[141]DrakeMJetal.Comparativeassessmentoftheef?cacyof
[128]QueissertFetal.Arti?cialurinarysphinctercuffsizepredictsonabotulinumtoxinAandoraltherapies(anticholinergicsand
outcomeinmalepatientstreatedforstressincontinence:resultsmirabegron)foroveractivebladder:asystematicreviewand
ofalargecentralEuropeanmulticentercohortstudy.Intnetworkmeta-analysis.BJUInt2017;120:611–22.
NeurourolJ2019;23:219–25.[142]ChughtaiBetal.Randomized,double-blind,placebocontrolled
[129]KaihoYetal.Surgicalandpatientreportedoutcomesofarti?cialpilotstudyofintradetrusorinjectionsofonabotulinumtoxinAfor
urinarysphincterimplantation:amulticenter,prospective,thetreatmentofrefractoryoveractivebladderpersistingfollowing
observationalstudy.JUrol2018;199:245–50.surgicalmanagementofbenignprostatichyperplasia.CanJUrol
[130]SaccoEetal.Arti?cialurinarysphinctersigni?cantlybetterthan2014;21:7217–21.
?xedslingformoderatepost-prostatectomystressurinary[143]FaureWalkerNAetal.OnabotulinumtoxinAInjectionsinMen
incontinence:apropensityscore-matchedstudy.BJUIntWithRefractoryIdiopathicDetrusorOveractivity.Urology
2021;127:229–37.2019;123:242–6.
[131]OstrowskiIetal.PreliminaryoutcomesoftheEuropean[144]CuiYetal.Botulinumtoxin-Ainjectionsforidiopathicoveractive
multicentreexperiencewiththeZSI375arti?cialurinarybladder:asystematicreviewandmeta-analysis.UrolInt2013;91:
sphincterfortreatmentofstressurinaryincontinenceinmen.429–38.
CentEuropeanJUrol2019;72:263–9.[145]BelsJetal.Long-termfollow-upofintravesicalonabotulinum
[132]LlorensCetal.Urinaryarti?cialsphincterZSI375fortreatmentoftoxin-Ainjectionsinmalepatientswithidiopathicoveractive
stressurinaryincontinenceinmen:5and7yearsfollow-upbladder:comparingsurgery-na?vepatientsandpatientsafter
report.UrolJ2017;84:263–6.prostatesurgery.EurUrolFocus2021;7:1424–9.
[133]deBarrosEGCetal.Arti?cialsphincter‘‘BR-SL-AS904’’inthe[146]TutoloMetal.Ef?cacyandsafetyofsacralandpercutaneoustibial
treatmentofurinaryincontinenceafterradicalprostatectomy:neuromodulationinnon-neurogeniclowerurinarytract
ef?cacy,practicalityandsafetyinaprospectiveandmulticenterdysfunctionandchronicpelvicpain:asystematicreviewofthe
study.IntBrazJUrol2018;44:1215–23.literature.EurUrol2018;73:406–18.
[134]LarsonTetal.Adjustablecontinencetherapy(ProACT)forthe[147]VennSNetal.Long-termresultsofaugmentationcystoplasty.Eur
treatmentofmalestressurinaryincontinence:asystematicUrol1998;34(Suppl1):40–2.
reviewandmeta-analysis.NeurourolUrodyn2019;38:2051–9.[148]El-AzabASetal.Thesatisfactionofpatientswithrefractory
[135]CrivellaroSetal.Adjustablecontinencetherapy(ProACT)andidiopathicoveractivebladderwithonabotulinumtoxinAand
boneanchoredmalesling:comparisonoftwonewtreatmentsofaugmentationcystoplasty.ArabJUrol2013;11:344–9.
postprostatectomyincontinence.IntJUrol2008;15:910–4.[149]HoenLetal.Long-termeffectivenessandcomplicationratesof
[136]RoupretMetal.Managementofstressurinaryincontinencebladderaugmentationinpatientswithneurogenicbladder
followingprostatesurgerywithminimallyinvasiveadjustabledysfunction:asystematicreview.NeurourolUrodyn2017;36:
1685–702.
Pleasecitethisarticleas:M.Gacci,V.I.Sakalis,M.Karavitakisetal.,EuropeanAssociationofUrologyGuidelinesonMaleUrinaryIncontinence,Eur
Urol(2022),https://doi.org/10.1016/j.eururo.2022.05.012 |
|
